Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy-Reference-Cited by-同舟云学术

Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy

Published:2022-07-01 Issue:7 Volume:158 Page:779
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Zhao Hanxi¹,Zhu Wanqi¹,Zhao Xianguang¹,Li Xiaolin¹,Zhou Zhengbo²,Zheng Meizhu²,Meng Xiangjiao¹,Kong Lingling¹,Zhang Shuyu³,He Dan³,Xing Ligang¹,Yu Jinming¹

Affiliation:

1. Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China

2. Department of Breast Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China

3. Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 416 Hospital), Chengdu, China

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2792713/jamadermatology_zhao_2022_oi_220023_1657583968.38728.pdf

Reference37 articles.

1. Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions.;Oluwasanu;Lancet Glob Health,2020

2. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.;Bartelink;Lancet Oncol,2015

3. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.;Clarke;Lancet,2005

4. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.;Fisher;N Engl J Med,2002